Page last updated: 2024-08-24

1,7-phenanthroline and Nasopharyngeal Neoplasms

1,7-phenanthroline has been researched along with Nasopharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, YX; Chan, AT; Fung, KP; Lam, CW; Leung, PC; Leung, SF; Li, PW; Wong, CK; Wong, EL; Yin, YB	1

Trials

1 trial(s) available for 1,7-phenanthroline and Nasopharyngeal Neoplasms

Article	Year
Clinical studies of immunomodulatory activities of Yunzhi-Danshen in patients with nasopharyngeal carcinoma. Journal of alternative and complementary medicine (New York, N.Y.), 2006, Volume: 12, Issue:8 Topics: Adult; Aged; Capsules; CD4-Positive T-Lymphocytes; Double-Blind Method; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Hong Kong; Humans; Immunity, Cellular; Immunologic Factors; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Nasopharyngeal Neoplasms; Phenanthrolines; Salvia miltiorrhiza; Treatment Outcome	2006

Article

Year

Clinical studies of immunomodulatory activities of Yunzhi-Danshen in patients with nasopharyngeal carcinoma.

Journal of alternative and complementary medicine (New York, N.Y.), 2006, Volume: 12, Issue:8

Topics: Adult; Aged; Capsules; CD4-Positive T-Lymphocytes; Double-Blind Method; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Hong Kong; Humans; Immunity, Cellular; Immunologic Factors; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Nasopharyngeal Neoplasms; Phenanthrolines; Salvia miltiorrhiza; Treatment Outcome

2006